US Stock MarketDetailed Quotes

BAX Baxter International Inc

Watchlist
  • 34.510
  • -0.420-1.20%
Close Feb 28 16:00 ET
  • 34.600
  • +0.090+0.26%
Post 20:01 ET
17.66BMarket Cap-27.17P/E (TTM)

Baxter International Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Baxter International Inc Q4 2024 Earnings Date

Currency：USDFeb 20, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.67B
2.75B
+79.07M
Beat Est.
-31.17%
+0.99%
+2.96%
EPS
0.18
-1.00
-1.18
Miss Est.
-63.54%
-308.33%
-671.43%
Analyst Rating
Buy

Feb 28, 2025

Baxter International Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.833B--
--2025/Q1-- / 2.588B--
Feb 20, 20252024/Q42.753B / 2.674B--
Nov 8, 20242024/Q32.699B / 3.847B--
Aug 6, 20242024/Q23.812B / 3.752B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.833B--
--2025/Q1-- / 2.588B--
Feb 20, 20252024/Q42.753B / 2.674B--
Nov 8, 20242024/Q32.699B / 3.847B--
Aug 6, 20242024/Q23.812B / 3.752B--

Unlock Free Earnings Estimates

Baxter International Inc Earnings Reports

  • Baxter International Inc | 10-K: FY2024 Annual Report

    Feb 21 17:17 ET

  • Baxter International Inc | 8-K: BAXTER REPORTS FOURTH-QUARTER AND FULL-YEAR 2024 RESULTS

    Feb 20 07:21 ET

  • Baxter International Inc | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:45 ET

  • Baxter International Inc | 8-K: BAXTER REPORTS THIRD-QUARTER 2024 RESULTS

    Nov 8, 2024 07:20 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      40.00%

    • Hold

      50.00%

    • Sell

      10.00%

    Price Target

    No Data